Clinical Trials in Baltimore

Showing 13201-13220 of 20,142 trials

Long Term Split Belt Treadmill Training for Stroke Recovery

NCT01646216

The purpose of this study is to determine whether split belt or conventional treadmill training can be used to treat walking pattern deficits from stroke and to determine whether this improves gait asymmetry and metabolic efficiency.

StrokeHemiparesis

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.34 participantsStarted Jun 2012

Baltimore, Maryland, United States

TERMINATEDPhase 2< 1 mile

Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome

NCT01552681

The purpose of the study is to find out if the experimental study agent, baminercept, is effective in treating patients with Sjögren's syndrome. The study will also determine if the study agent can be safely given to patients with Sjögren's syndrome; examine how it affects symptoms of the disease; and attempt to understand how baminercept affects the underlying mechanisms of Sjögren's syndrome and the immune system.

Primary Sjögren's Syndrome

National Institute of Allergy and Infectious Diseases (NIAID)52 participantsStarted Jul 2012

Los Angeles, California, United States • Palo Alto, California, United States • Hartford, Connecticut, United States +6 more locations

Long Term Split Belt Treadmill Training for Stroke Recovery

Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome

Find Trials by Condition in Baltimore

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC

Norovirus Bivalent-Vaccine Efficacy Study

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

Migrant and Seasonal Head Start Study

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

A Safety Study in Participants With Advanced Solid Tumors

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Detection of Cytomegalovirus Virus in Neonates